Cargando…

Sucrosomial(®) Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation

Sucrosomial(®) Iron is a recently developed formulation to treat iron deficiency based on ferric pyrophosphate covered by a matrix of phospholipids plus sucrose esters of fatty acids. Previous data indicated that Sucrosomial(®) Iron is efficiently absorbed by iron-deficient subjects, even at low dos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asperti, Michela, Gryzik, Magdalena, Brilli, Elisa, Castagna, Annalisa, Corbella, Michela, Gottardo, Rossella, Girelli, Domenico, Tarantino, Germano, Arosio, Paolo, Poli, Maura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213119/ https://www.ncbi.nlm.nih.gov/pubmed/30241424 http://dx.doi.org/10.3390/nu10101349

Ejemplares similares

Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments
por: Asperti, Michela, et al.
Publicado: (2021)

Sucrosomial(®) Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency
por: Gómez-Ramírez, Susana, et al.
Publicado: (2023)

Sucrosomial(®) Iron: A New Generation Iron for Improving Oral Supplementation
por: Gómez-Ramírez, Susana, et al.
Publicado: (2018)

Heparanase Overexpression Reduces Hepcidin Expression, Affects Iron Homeostasis and Alters the Response to Inflammation
por: Asperti, Michela, et al.
Publicado: (2016)

High Sulfation and a High Molecular Weight Are Important for Anti-hepcidin Activity of Heparin
por: Asperti, Michela, et al.
Publicado: (2016)

Hepcidin antagonists for potential treatments of disorders with hepcidin excess
por: Poli, Maura, et al.
Publicado: (2014)

Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice
por: Poli, Maura, et al.
Publicado: (2019)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
por: Poli, Maura, et al.
Publicado: (2017)

Ex Vivo and in Vivo Study of Sucrosomial(®) Iron Intestinal Absorption and Bioavailability
por: Fabiano, Angela, et al.
Publicado: (2018)

Supplementation with Sucrosomial® iron leads to favourable changes in the intestinal microbiome when compared to ferrous sulfate in mice
por: Zakrzewski, Martha, et al.
Publicado: (2021)

S283: THE NON-ANTICOAGULANT HEPARINOID COMPOUND, SEVUPARIN, STRONGLY REDUCES HEPCIDIN EXPRESSION IN CELLS, IN MICE AND IN HEALTHY VOLUNTEERS
por: Asperti, Michela, et al.
Publicado: (2023)

The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells
por: Asperti, Michela, et al.
Publicado: (2019)

Biochemical, Biophysical and Functional Characterization of an Insoluble Iron Containing Hepcidin–Ferritin Chimeric Monomer Assembled Together with Human Ferritin H/L Chains at Different Molar Ratios
por: Boumaiza, Mohamed, et al.
Publicado: (2021)

In Vitro and In Vivo Sucrosomial(®) Berberine Activity on Insulin Resistance
por: Lupo, Maria Giovanna, et al.
Publicado: (2022)

The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo
por: Asperti, Michela, et al.
Publicado: (2023)

Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study()
por: Campostrini, Natascia, et al.
Publicado: (2012)

Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study
por: Martinelli, Nicola, et al.
Publicado: (2012)

Correction: Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study
por: Martinelli, Nicola, et al.
Publicado: (2013)

Comparative Evaluation of Sucrosomial Iron and Iron Oxide Nanoparticles as Oral Supplements in Iron Deficiency Anemia in Piglets
por: Mazgaj, Rafał, et al.
Publicado: (2021)

Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes
por: Santini, Valeria, et al.
Publicado: (2011)

Iron deficiency in the elderly population, revisited in the hepcidin era
por: Busti, Fabiana, et al.
Publicado: (2014)

Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25
por: Cenci, Lucia, et al.
Publicado: (2015)

Evaluation of Hepcidin Isoforms in Hemodialysis Patients by a Proteomic Approach Based on SELDI-TOF MS
por: Campostrini, Natascia, et al.
Publicado: (2010)

Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment
por: Bastida, Guillermo, et al.
Publicado: (2021)

The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis
por: Pelusi, Serena, et al.
Publicado: (2013)

New Advances in Iron Metabolism, Ferritin and Hepcidin Research
por: Arosio, Paolo
Publicado: (2022)

A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels
por: Lira Zidanes, Acaynne, et al.
Publicado: (2020)

Sucrosomial Iron Supplementation in Anemic Patients with Celiac Disease Not Tolerating Oral Ferrous Sulfate: A Prospective Study
por: Elli, Luca, et al.
Publicado: (2018)

Effect of Oral Supplementation of Healthy Pregnant Sows with Sucrosomial Ferric Pyrophosphate on Maternal Iron Status and Hepatic Iron Stores in Newborn Piglets
por: Mazgaj, Rafał, et al.
Publicado: (2020)

Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy
por: Busti, Fabiana, et al.
Publicado: (2018)

Effect of Sucrosomial(®) Iron and Iron Drop Diluted with Natural Fruit Juice on Microhardness of Primary Enamel
por: Sahebnazar, Nika, et al.
Publicado: (2022)

Sucrosomial® iron effectiveness in recovering from mild and moderate iron-deficiency anemia in the postpartum period
por: Antoine, Edu, et al.
Publicado: (2023)

Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis
por: Bertani, Lorenzo, et al.
Publicado: (2021)

S288: DIFFERENTIAL RECOVERY OF MACROPHAGE IRON DEFICIENCY BY ORAL IRON FORMULATIONS DETERMINES CELL INFLAMMATORY ACTIVATION IN ANEMIC CONDITIONS
por: Antypiuk, Ada, et al.
Publicado: (2023)

Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics
por: Skrypnik, Katarzyna, et al.
Publicado: (2020)

Pilot Study to Gain First Indications for the Impact of a 3-Month's Oral Intake of a Sucrosomial Iron Supplement on Hemoglobin in Iron-Deficient Blood Donors
por: Torreiter, Patrick Paul, et al.
Publicado: (2022)

Urinary Hepcidin Levels in Iron-Deficient and Iron-Supplemented Piglets Correlate with Hepcidin Hepatic mRNA and Serum Levels and with Body Iron Status
por: Staroń, Robert, et al.
Publicado: (2015)

Iron as Therapeutic Target in Human Diseases
por: Gozzelino, Raffaella, et al.
Publicado: (2019)

Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
por: Riccio, Eleonora, et al.
Publicado: (2020)

Analysis of Nucleotide Variations in Genes of Iron Management in Patients of Parkinson's Disease and Other Movement Disorders
por: Castiglioni, Emanuela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_o64qe0tu7kojsfeep47t1eepia